Clin. Prof Michael Hughes
publications

San Publications

​

• Multidiscliplinary Breast Cancer Care

• Breast cancer neoadjuvent systemic therapy - a breast surgeon's perspective

• A patient with a newly diagnosed early breast cancer - dilemmas in workup and management

​

Journal Publications - Peer Reviewed

​

1. Paraneoplastic myelopathy at diagnosis in a patient with pathologic stage 1A Hodgkin disease

2. A Case of Rectal Infarction after Sigmoid Colectomy for Traumatic Perforation in a Patient with a Major Pelvic Fracture

3. Mammographically Negative Breast Cancer at the Strathfield Breast Centre

4. Angiographic embolisation in pelvic fracture

5. The Diagnosis of Gastrointestinal Tract Injuries Resulting from Blunt Trauma

6. Combined inguinal and pelvic lymph node dissection for stage III melanoma

7. Sarcoma metastases due to iatrogenic implantation

8. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma

9. Imaging of soft tissue tumours

10. Duplicated Popliteal and Superficial Femoral Veins: Incidence and Potential Significance

11. Perinatal inferior vena cava thrombosis and absence of the infrarenal inferior vena cava

12. Surgical resection for metastatic melanoma to the liver

13. The pathophysiology and management of bowel and mesenteric injuries due to blunt trauma

14. Intra-abdominal gastrointestinal tract injuries following blunt trauma: the experience of an Australian trauma centre

15. An empirical study of the psychological consequences of genetic testing for melanoma susceptibility

16. Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy)

17. Merkel Cell Carcinoma: Improved Outcome with Adjuvant Radiotherapy

18. Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes

19. Interobserver variation in the histopathologic reporting of key prognostic factors, particularly Clark level, affects pathologic staging of primary cutaneous melanoma

20. Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma

21. Biopsy Diagnosis of Early Myositis Ossificans Without Radiologic Evidence of Calcification

22. Systemic Mastocytosis and surgery a potential disaster

23. Merkel cell carcinoma: An Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients

24. Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer

25. Malignant phyllodes: excellent response to neoadjuvant radiotherapy

26. Indications for and impact of Oncotype DX on adjuvant treatment recommendations when third party funding is unavailable

27. Gastric band tubing causing cecal volvulus

28. Effect of the American College of Surgeons Oncology Group Z0011 trial on axillary management in breast cancer patients in the Australian setting

29. New treatment paradigms for clinically apparent metastatic melanoma in regional lymph nodes

30. Pathological outcomes of HER2-positive non-metastatic breast cancer patients treated with neoadjuvant dual anti-HER2 therapy and taxane: An Australian experience

31. Implementing a prospective surveillance and early intervention model of care for breast cancer-related lymphedema into clinical practice: application of the RE-AIM framework

32. Desmoplastic melanoma: A review of its pathology and clinical behaviour, and of recommendations in published guidelines

33. The association of neoadjuvant systemic treatment on hormone receptor and Her2 expression in breast cancer

34. A comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention

35. The Oncotype DX assay use in breast cancer in an Australian institutional setting

36. Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers

37. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention

38. Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridisation

39. Prospective surveillance with compression for subclinical lymphedema: Symptoms, skin and quality of life outcomes

40. Re-irradiation after radical dose radiotherapy: a case report challenging an established dogma

41. An update on Radiation-Induced Angiosarcoma of the Breast: A Diagnostic and Management Challenge

42. Has COVID-19 pandemic resulted in more advanced breast cancer? A hopsital-based retrospective study

43. Breast desmoid tumours: A systematic review of the literature

44. Pathological and Clinical Outcomes following neoadjuvant dual HER2 therapy for early-stage breast cancer: An Australian institutional real-world experience

45. Oncoplastic Breast Surgery – a Pictorial Classification System for Surgeons and Radiation Oncologists

46. Clinical impact of the Z0011 Trial on axillary surgical management in Australia and New Zealand from the BreastSurgANZ Quality Audit

47. Radiation induced morphea of the breast following radiotherapy for breast cancer

48. The care of complex skin cancer in rural New South Wales, Australia – Results of a pilot study of primary care physicians